Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 18;10(3):e0020.
doi: 10.5041/RMMJ.10373.

Long-term Follow-up of Severe Eosinophilic Hepatitis: A Rare Presentation of Hypereosinophilic Syndrome

Affiliations

Long-term Follow-up of Severe Eosinophilic Hepatitis: A Rare Presentation of Hypereosinophilic Syndrome

Halim Awadie et al. Rambam Maimonides Med J. .

Abstract

Idiopathic hypereosinophilic syndrome (HES) is a rare, heterogeneous disorder characterized by a strikingly high eosinophil count (>1,500 cells/μL), over a long period of time (>6 months), with end organ damage. We present a 60-year-old patient with idiopathic HES with isolated liver involvement, a rare systemic disease and a rare solid organ involvement. The patient had a thorough investigational work up until HES was established, including liver biopsy. He needed intensive immunosuppressive treatment at first with steroids, then with azathioprine in conjunction with a low dose of steroids. After 16 years of follow-up, the patient showed no evidence of liver dysfunction. To the best of our knowledge, this is the longest follow-up for a patient with HES-associated chronic hepatitis. Our observation suggests that, with appropriate treatment, liver involvement in HES may be well controlled without deterioration to advanced liver failure.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: No potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1
Liver Biopsy at First Evaluation and Repeated Biopsy Four Years Later. A liver needle biopsy taken within the first evaluation showed preserved lobular architecture (A, HE 4×) and mild portal inflammation with several eosinophils seen in the infiltrate (B, HE 40×). Masson trichrome stain showed focal bridging fibrosis (C, trichrome 4×). A second biopsy taken four years later showed portal inflammation (D, HE 4×) with fewer eosinophils in the infiltrates (E, HE 40×) and no change in fibrosis (F, trichrome 4×). White arrowheads indicate eosinophils.
Figure 2
Figure 2
Eosinophilic Count, Liver Function Tests, and Enzymes from Presentation to Date. ALP, alkaline phosphatase (U/L); ALT, alanine transaminase (U/L); AST, aspartate transaminase (U/L); Bil Direct, bilirubin direct (mg/dL); Bil Total, bilirubin total (mg/dL); Eos, eosinophils (×103/μL); GGT, gamma-glutamyl transpeptidase (U/L); Max, worst value during hospitalization; Spont, spontaneous improvement; Steroids & Aza, concomitant treatment of steroids an azathioprine; Tapering, tapering down of steroids.

References

    1. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med. 1982;97:78–92. doi: 10.7326/0003-4819-97-1-78. - DOI - PubMed
    1. Minola E, Sonzogni A. Chronic hepatitis in hypereosinophilic syndrome: report of an unusual case. Infez Med. 2005;13:182–6. - PubMed
    1. Butt NM, Lambert J, Ali S, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176:553–72. doi: 10.1111/bjh.14488. - DOI - PubMed
    1. Croffy B, Kopelman R, Kaplan M. Hypereosinophilic syndrome. Association with chronic active hepatitis. Dig Dis Sci. 1988;33:233–9. - PubMed
    1. Kim YJ, Jeon JH, Kim NS, Ryu JS, Hong EK. Eosinophil-induced chronic hepatitis. J Korean Med Sci. 1998;13:219–22. doi: 10.3346/jkms.1998.13.2.219. - DOI - PMC - PubMed

LinkOut - more resources